Rapid Micro Biosystems (RPID) 43rd Annual J.P. Morgan Healthcare Conference 2025 summary

Business Overview and Market Context

• Focuses on automating microbial quality control in pharmaceutical manufacturing, a process largely unchanged for a century.

• Growth Direct platform replaces manual, error-prone, and slow QC processes with automation and data integrity, operating in about 20 countries with 70% of the top 20 global pharma companies as customers.

• Over 160 Growth Direct systems placed globally, with more than 135 validated for GMP use and 21 new systems placed in 2024.

• Especially strong in biologics, cell and gene therapy manufacturing, and 100% of approved CAR-T manufacturers as customers.

• Collaboration with Lonza enables end-to-end automation of microbial quality control testing across cell & gene manufacturing networks.

Financial Performance and Growth

• 2024 revenue reached $28.1 million, representing 25% year-on-year growth and record Q4 revenue of $8.2 million.

• Recurring revenue accounted for at least $15.5 million, over 50% of total, driven by consumables and services.

• Achieved positive gross margins in Q3 and Q4 2024, with gross margins up 50 percentage points from 2022 to 2024.

• 28% revenue CAGR from 2022 to 2024, with a high-growth, recurring revenue model.

• Targeting positive cash flow by end of 2027 without additional financing.

Industry Trends and Market Drivers

• Pharma industry faces increasing regulatory scrutiny, demand for data integrity, and a shift toward automation in quality control.

• Growth in complex biologics, cell & gene therapies, and a $10B+ market opportunity are driving adoption of automated MQC solutions.

• Traditional MQC labs are manual, slow, and prone to error, creating a strong business case for digital transformation.

• Regulatory and operational pressures are accelerating the need for faster, more accurate, and secure testing platforms.

• The Growth Direct platform is positioned as the industry standard for automating microbial quality control.